|
14 (PB002): Discovery of NKT3964: a first-in-class, highly potent and selective, orally bioavailable CDK2 PROTAC degrader for cancer therapy |
|
|
|
Titel: |
14 (PB002): Discovery of NKT3964: a first-in-class, highly potent and selective, orally bioavailable CDK2 PROTAC degrader for cancer therapy |
Auteur: |
Geng, J. Liu, K. Yu, Z. Sun, W. Yeh, Y.T. Wei, H. Li, W. Lu, J. Deng, J. Yang, C. Geng, L. Luo, X. Liu, Z. Gao, Z. Lou, Y. |
Verschenen in: |
European journal of cancer |
Paginering: |
Jaargang 211 () nr. S1 pagina's p. |
Jaar: |
2024 |
Inhoud: |
|
Uitgever: |
Elsevier LTD. All rights reserved. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|